Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Journal:

The New England Journal of Medicine

Published:

2025-06-01

DOI:

10.1056/nejmoa2503119

Affiliations:

26

Authors:

25

Go to article

Institutions	Authors	Share
Daiichi Sankyo US, United States of America (USA)	4.000000	0.16
Centre Léon Bérard (CLB), France	2.000000	0.08
CHRU Brest, France	1.000000	0.04
Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), Portugal	1.000000	0.04
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.04
National Cancer Center Hospital East, Japan	1.000000	0.04
The Christie NHS Foundation Trust, United Kingdom (UK)	1.000000	0.04
University Hospital of Pisa, UNIPI, Italy	1.000000	0.04
Shandong Cancer Hospital, China	1.000000	0.04
Samsung Medical Center (SMC), South Korea	1.000000	0.04
University Hospitals Leuven (UZ Leuven), Belgium	1.000000	0.04
IRCCS National Cancer Institute (INT) Milan, Italy	1.000000	0.04
Catholic University of Leuven (KU Leuven), Belgium	1.000000	0.04
Centro de Pesquisa Clinica em Oncologia (ONCOSITE), Brazil	1.000000	0.04
IRCCS Istituto Oncologico Veneto (IOV), Italy	1.000000	0.04
University College Hospital Macmillan Cancer Centre, United Kingdom (UK)	1.000000	0.04
Georges Pompidou European Hospital (HEGP), France	0.500000	0.02
Paris Cité University, France	0.500000	0.02
University of Vic - Central University of Catalonia (UVic-UCC), Spain	0.500000	0.02
Istanbul Medeniyet University (IMU), Turkey	0.500000	0.02
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, China	0.500000	0.02
Asan Medical Center (AMC), South Korea	0.500000	0.02
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	0.500000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.02
University of Ulsan (UOU), South Korea	0.500000	0.02
Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Turkey	0.500000	0.02

Interested in Oncology and Carcinogenesis?